Immunovant Inc’s recent filing unveils that its Chief Financial Officer Barnett Eva Renee unloaded Company’s shares for reported $98930.0 on Jan 08 ’25. In the deal valued at $24.10 per share,4,105 shares were sold. As a result of this transaction, Barnett Eva Renee now holds 327,064 shares worth roughly $7.48 million.
Then, Salzmann Peter sold 5,105 shares, generating $123,030 in total proceeds. Upon selling the shares at $24.10, the Chief Executive Officer now owns 972,992 shares.
Before that, Pande Atul sold 7,750 shares. Immunovant Inc shares valued at $221,185 were divested by the Director at a price of $28.54 per share. As a result of the transaction, Pande Atul now holds 86,663 shares, worth roughly $1.98 million.
Wolfe Research downgraded its Immunovant Inc [IMVT] rating to a Peer perform from a an Outperform in a research note published recently. Oppenheimer also remained covering IMVT and reiterated its “an Outperform” recommendation on October 09, 2024. Oppenheimer started covering the stock on March 28, 2024. It rated IMVT as “an Outperform”.
Price Performance Review of IMVT
On Tuesday, Immunovant Inc [NASDAQ:IMVT] saw its stock jump 0.57% to $22.88. Over the last five days, the stock has lost -7.11%. Immunovant Inc shares have fallen nearly -7.63% since the year began. Nevertheless, the stocks have fallen -46.63% over the past one year. While a 52-week high of $42.44 was reached on 01/02/25, a 52-week low of $22.41 was recorded on 01/13/25. SMA at 50 days reached $27.09, while 200 days put it at $28.60.
Levels Of Support And Resistance For IMVT Stock
The 24-hour chart illustrates a support level at 22.14, which if violated will result in even more drops to 21.39. On the upside, there is a resistance level at 24.31. A further resistance level may holdings at 25.73. The Relative Strength Index (RSI) on the 14-day chart is 30.98, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.44, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.40%. Stochastics %K at 10.60% indicates the stock is a buying.
How much short interest is there in Immunovant Inc?
A steep rise in short interest was recorded in Immunovant Inc stocks on 2024-12-31, dropping by -0.4 million shares to a total of 12.26 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 12.67 million shares. There was a decline of -3.3%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 13, 2024 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
